Gastrointestinal symptom representation in cancer symptom clusters: a synthesis of the literature
- PMID: 22374489
- PMCID: PMC3365541
- DOI: 10.1188/12.ONF.157-165
Gastrointestinal symptom representation in cancer symptom clusters: a synthesis of the literature
Abstract
Purpose/objectives: To review how gastrointestinal (GI)symptoms are represented within symptom clusters in patients with cancer receiving chemotherapy.
Data sources: MedLINE, PsycINFO, and CINAHL.
Data synthesis: Forty-two symptom clusters containing a GI component emerged. Only four clusters were replicated in different samples; 38 were unique clusters. Thirteen different symptom measurement tools were used across the studies. Nineteen different GI symptoms were measured; however, many chemotherapy- or cancer-related GI symptoms known to be present in this population were missing or underrepresented. Twenty-one of the studies reviewed identified a symptom cluster that was primarily (50% or greater) composed of GI symptoms.
Conclusions: GI symptoms are prevalent in symptom clusters, but those clusters often are inconsistent. One explanation for this finding may be that current symptom measurement tools do not fully address GI symptoms commonly experienced by patients receiving chemotherapy.
Implications for nursing: Future research should focus on using a comprehensive symptom assessment tool in a homogenous sample of participants who are receiving chemotherapy. Improved measurement of GI symptoms will advance symptom cluster research, which could impact assessment of chemotherapy-related symptoms and development of interventions for symptom clusters.
Similar articles
-
Distress-Based Gastrointestinal Symptom Clusters and Impact on Symptom Interference and Quality of Life in Patients with a Hematologic Malignancy Receiving Chemotherapy.J Pain Symptom Manage. 2017 Apr;53(4):751-758. doi: 10.1016/j.jpainsymman.2016.11.005. Epub 2016 Dec 29. J Pain Symptom Manage. 2017. PMID: 28042061
-
Prevalence, Duration, Severity, and Distress of Chemotherapy-Related Gastrointestinal Symptoms in Patients With a Hematologic Malignancy.Oncol Nurs Forum. 2016 Sep 1;43(5):561-71. doi: 10.1188/16.ONF.43-05AP. Oncol Nurs Forum. 2016. PMID: 27541549
-
Symptom Clusters That Included Gastrointestinal Symptoms Among Children Receiving Cancer Treatments: A Scoping Review.Oncol Nurs Forum. 2023 Apr 21;50(3):381-395. doi: 10.1188/23.ONF.381-395. Oncol Nurs Forum. 2023. PMID: 37155980
-
Systematic Review of Nonpharmacologic Approaches for the Management of Gastrointestinal Symptoms.Oncol Nurs Forum. 2019 Jan 13;46(1):E1-E21. doi: 10.1188/19.ONF.E1-E21. Oncol Nurs Forum. 2019. PMID: 30547953
-
Stability of Symptom Clusters in Patients With Gastrointestinal Cancers Receiving Chemotherapy.J Pain Symptom Manage. 2019 Dec;58(6):989-1001.e10. doi: 10.1016/j.jpainsymman.2019.07.029. Epub 2019 Aug 9. J Pain Symptom Manage. 2019. PMID: 31404646 Free PMC article.
Cited by
-
Systemic Diseases and Gastrointestinal Cancer Risk.J Cancer Allied Spec. 2023 Aug 13;9(2):473. doi: 10.37029/jcas.v9i2.473. eCollection 2023. J Cancer Allied Spec. 2023. PMID: 37575213 Free PMC article. Review.
-
Distress among cancer patients attending rehabilitation in the community.Support Care Cancer. 2022 Jan;30(1):279-287. doi: 10.1007/s00520-021-06422-3. Epub 2021 Jul 17. Support Care Cancer. 2022. PMID: 34273033 Free PMC article.
-
The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis.Support Care Cancer. 2023 Apr 25;31(5):297. doi: 10.1007/s00520-023-07759-7. Support Care Cancer. 2023. PMID: 37097532 Free PMC article.
-
Proton pump inhibitors may increase the risk of cisplatin-induced acute kidney injury in patients with nasopharyngeal carcinoma: a prospective cohort study.Sci Rep. 2024 Aug 13;14(1):18839. doi: 10.1038/s41598-024-69821-6. Sci Rep. 2024. PMID: 39138312 Free PMC article.
-
A Review of the Clinical Implications of Cachexia, Sarcopenia, and BMI in Patients with Peritoneal Carcinomatosis Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Cancers (Basel). 2022 Jun 9;14(12):2853. doi: 10.3390/cancers14122853. Cancers (Basel). 2022. PMID: 35740519 Free PMC article. Review.
References
-
- Baker PD, Morzorati SL, Ellett ML. The pathophysiology of chemotherapy-induced nausea and vomiting. Gastroenterology Nursing. 2005;28:469–480. - PubMed
-
- Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: Conceptual, design, measurement, and analysis issues. Journal of Pain and Symptom Management. 2006;31:85–95. - PubMed
-
- Berger AM, Clark-Snow RA. Chemotherapy-related nausea and vomiting. In: Berger AM, Shuster JL Jr, von Roenn JH, editors. Principles and practice of palliative care and supportive oncology. Philadelphia, PA: Lippincott-Raven; 2007. pp. 139–149.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources